Paul Boucher
CEO and President at Parion Sciences, Inc.- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
Raleigh, US
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Experience
-
Parion Sciences
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
CEO and President
-
Apr 2014 - Present
Durham, NC Parion is a privately held, development stage pharmaceutical company focused is on treating unmet respiratory indications resulting from defects of the innate mucosal defense. Parion's pipeline includes a diverse range of novel small molecules for the treatment of Primary Ciliary Dyskinesia, Cystic Fibrosis, COPD, and Asthma. Our lead program, P-1037 Inhalation Solution, has the potential to be the first-in-class treatment for the severe, rare disease, Primary Ciliary Dyskinesia.
-
-
-
-
VP, Finance and Business
-
Jan 2006 - Mar 2012
Durham, NC
-
-
-
-
Corporate Account Manager
-
Jan 2005 - Jan 2006
Torrance, Ca
-
-
-
-
Senior Real Estate Portfolio Associate
-
Aug 2002 - Jan 2005
Torrance, CA
-
-
Graduate Management Associate
-
Aug 2000 - Jul 2002
Torrance, CA
-
-
Education
-
UNC Kenan-Flagler Business School
-
University of North Carolina at Chapel Hill
Master of Business Administration (M.B.A.) -
Rensselaer Polytechnic Institute
BS, Civil Engineering
Community
You need to have a working account to view this content.
Click here to join now